Press Releases   Media Coverage     MEDIA COVERAGE   PATENTS Mashelkar panel to look into Patentability Criteria for Pharmaceuticals   The central government has constituted a five-member Technical Expert Group to look into the areas of concern in the amended Patent Act.   The committee is headed by Dr. R.A.Mashelkar, Director General, Council of Scientific and Industrial Research(CSIR), New Delhi(Chairman). The members of the group are Prof. Goverdhan Mehta, Director, Indian Institute of Science, Bangalore; Prof. Asis Datta, Director, National Centre for plant Genome Research, NewDelhi; Prof. Madhav Menon, National Judicial Academy, Bhopal; and Prof. Moolchand Sharma, Director, National Law Institute University, Bhopal as members.   The terms of reference of the Group are to see if it would be TRIPs(Trade Related Intellectual Property Rights) compatible to limit the grant of patent for pharmaceutical substants to new chemical entity or to new medical entity involving one or more inventing steps. The group will also study if it would be TRIPs compatible to exclude microorganisms from patenting.   The setting up of committee is a direct follow-up of the assurance given by union commerce minister Kamal Nath while moving the official amendments to the patents(Ammendment) Bill 2005 in the Lok Sabha on March 22. The minister has said that the issue of patent availability of new chemical entities and new microorganisms would be referred to an Expert Committee and as a result any amendments were sugested to safeguard the interests of these products.They would be incorporated in the new legislation later.   Go back to media coverage

Privacy Policy     Disclaimer